As of the 15th of February 2026, Medexus Pharmaceuticals secures the Downside Deviation of 2.13, mean deviation of 1.7, and Risk Adjusted Performance of 0.0502. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medexus Pharmaceuticals, as well as the relationship between them.
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Medexus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Medexus
Medexus
Medexus Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Understanding that Medexus Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medexus Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Medexus Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Medexus Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medexus Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medexus Pharmaceuticals.
0.00
11/17/2025
No Change 0.00
0.0
In 3 months and 1 day
02/15/2026
0.00
If you would invest 0.00 in Medexus Pharmaceuticals on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Medexus Pharmaceuticals or generate 0.0% return on investment in Medexus Pharmaceuticals over 90 days. Medexus Pharmaceuticals is related to or competes with Cardiol Therapeutics. Medexus Pharmaceuticals is entity of Canada More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medexus Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medexus Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medexus Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medexus Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Medexus Pharmaceuticals historical prices to predict the future Medexus Pharmaceuticals' volatility.
As of now, Medexus Stock is relatively risky. Medexus Pharmaceuticals has Sharpe Ratio of 0.0505, which conveys that the firm had a 0.0505 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Medexus Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Medexus Pharmaceuticals' Risk Adjusted Performance of 0.0502, mean deviation of 1.7, and Downside Deviation of 2.13 to check out if the risk estimate we provide is consistent with the expected return of 0.12%. Medexus Pharmaceuticals has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.17, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medexus Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Medexus Pharmaceuticals is expected to be smaller as well. Medexus Pharmaceuticals right now secures a risk of 2.34%. Please verify Medexus Pharmaceuticals downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Medexus Pharmaceuticals will be following its current price movements.
Auto-correlation
-0.3
Weak reverse predictability
Medexus Pharmaceuticals has weak reverse predictability. Overlapping area represents the amount of predictability between Medexus Pharmaceuticals time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medexus Pharmaceuticals price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Medexus Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.3
Spearman Rank Test
-0.37
Residual Average
0.0
Price Variance
0.0
Medexus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Medexus Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Medexus Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
Medexus Pharmaceuticals Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Medexus Pharmaceuticals across different markets.
About Medexus Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Medexus Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Medexus Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Medexus Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Medexus Pharmaceuticals. By analyzing Medexus Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Medexus Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Medexus Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
Medexus Pharmaceuticals February 15, 2026 Technical Indicators
Most technical analysis of Medexus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Medexus from various momentum indicators to cycle indicators. When you analyze Medexus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Medexus Pharmaceuticals February 15, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Medexus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Medexus Pharmaceuticals financial ratios help investors to determine whether Medexus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medexus with respect to the benefits of owning Medexus Pharmaceuticals security.